27
LE BARS D, GOZARIU M, CADDEN SW. Animal models of nociception.
Pharmacol. Rev., 53, p. 597-652, 2001.
MELZACK, R. From the gate to the neuromatrix. Pain., v. Suppl 6, p. S121-6,
1999.
MELZACK, R. Pain and the neuromatrix in the brain. J. Dent. Educ., v. 65, p.1378-
82, 2001.
MELZACK, R.; WALL, P.D. Pain mechanisms: new theory. Science, v. 150, p.
971-979, 1965.
MURRELL, J.C.; JOHNSON. C.B. Neurophysiological techniques to assess pain in
animals. J. Vet. Pharmacol. Ther., v. 29, p. 325-335, 2006.
NANTEL, F. et al. Distribution and regulation of cyclooxygenase-2 in carrageenan-
induced inflammation. Br. J. Pharmacol., 128, p. 853-859, 1999.
PHILLIPS, W.J.; CURRIER, B.L. Analgesic pharmacology: I. Neurophysiology. J
Am. Acad. Orthop. Surg., v. 12, p. 213-220, 2004.
POSADAS, I. et al. Carrageenan-induced mouse paw oedema is biphasic, age-
weight dependent and displays differential nitric oxide cyclooxygenase-2
expression. Br. J. Pharmacol., v. 142, p. 331-338; 2004.
RAKEL, B.; Frantz, R.; Effectiveness of transcutaneous electrical nerve stimulation
on postoperative pain with movement. J. Pain., v. 8, p. 455-464, 2003.
RANG, H. P. ; DALE, M. M. E RITTER, J. M. Fármacos analgésicos. In: RANG, H.
P.; DALE, M. M. E RITTER, J. M. Farmacologia, Rio de Janeiro Guanabara
Koogan, 4ª Ed., 1999, p. 485-506.
RESENDE, M.A. et al. Local transcutaneous electrical stimulation (TENS) effects
in experimental inflammatory edema and pain. Eur. J. Pharmacol., v. 504, p. 217-
222, 2004.
RESENDE, M.A. et al. Reduction of effect analgesic of low frequencie
transcutaneous electrical nerve stimulation in rats morphine-tolerants. Rev. Br.
Fisiot., v. 10, p. 291-296, 2006.
ROBINSON, A. J., Transcutaneous electrical nerve stimulation for control of pain in
musculoskeletal. J.O.S.T., v. 24, p. 208-226, 1996